X T L Biopharmaceuticals reported $332K in Cost of Sales for its fiscal quarter ending in December of 2024.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Bioline Rx USD 95K 55K Mar/2026
Teva Pharmaceutical Industries USD 2.01B 46M Mar/2026
X T L Biopharmaceuticals USD 332K 216K Dec/2024